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Abstract
Background: In the present investigation, the effect of Curcuma longa (Cl) and Ocimum sanctum
(Os) on myocardial apoptosis and cardiac function was studied in an ischemia and reperfusion (I-
R) model of myocardial injury.
Methods: Wistar albino rats were divided into four groups and orally fed saline once daily (sham,
control IR) or Cl (100 mg/kg; Cl-IR) or Os (75 mg/kg; Os-IR) respectively for 1 month. On the 31st
day, in the rats of the control IR, Cl-IR and Os-IR groups LAD occlusion was undertaken for 45
min, and reperfusion was allowed for 1 h. The hemodynamic parameters{mean arterial pressure
(MAP), heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular peak
positive (+) LVdP/dt (rate of pressure development) and negative (-) LVdP/dt (rate of pressure
decline)} were monitored at pre-set points throughout the experimental duration and
subsequently, the animals were sacrificed for immunohistopathological (Bax, Bcl-2 protein
expression & TUNEL positivity) and histopathological studies.
Results: Chronic treatment with Cl significantly reduced TUNEL positivity (p < 0.05), Bax protein
(p < 0.001) and upregulated Bcl-2 (p < 0.001) expression in comparison to control IR group. In
addition, Cl demonstrated mitigating effects on several myocardial injury induced hemodynamic
{(+)LVdP/dt, (-) LVdP/dt & LVEDP} and histopathological perturbations. Chronic Os treatment
resulted in modest modulation of the hemodynamic alterations (MAP, LVEDP) but failed to
demonstrate any significant antiapoptotic effects and prevent the histopathological alterations as
compared to control IR group.
Conclusion: In the present study, significant cardioprotection and functional recovery
demonstrated by Cl may be attributed to its anti-apoptotic property. In contrast to Os, Cl may
attenuate cell death due to apoptosis and prevent the impairment of cardiac performance.
Background
Recently, the recognition of a different cell death phe-
nomenon 'Apoptosis' has become a major clinical inter-
est. It accounts for a great proportion of cell loss
associated with myocardial infarction (MI) and / or
ischemia-reperfusion (IR). Cell loss through apoptosis
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also plays an important role in myocardial remodeling
processes [1,2]. Induction of apoptosis is implicated in
myocardial I-R injury among other cardiovascular dis-
eases [3,4]. Various studies have demonstrated that not
only reactive oxygen species (ROS) per se, but also their
oxidation products and other secondary messenger mole-
cules generated by ROS can trigger the programmed cell
death [5]. It has been reported that these programmed cell
death pathways can be inhibited by antioxidants [6,7]
However, there are few studies addressing the inhibition
of apoptosis and it's directs on myocardial contractility.
Since apoptosis, is a genetically regulated process, hence,
a better understanding of the cellular mechanisms that
control apoptosis, could lead to defining novel and effec-
tive therapeutic strategies to limit the amount of tissue
damage in patients with MI [2-4].
Curcuma longa (Cl), common Indian dietary pigment and
spice has been shown to possess a wide range of therapeu-
tic utilities in the traditional Indian medicine. It's role in
wound healing, urinary tract infections, liver ailments are
well-documented [8]. The active component of turmeric
identified as curcumin exhibits a variety of pharmacolog-
ical effects including antioxidant, adaptogenic, anti-
inflammatory and anti-infectious activities [9,10]. Oci-
mum sanctum (Os), commonly known, as Tulsi in India is
a local herb containing potent antioxidants flavanoids
(orientin, vicenin) and phenolic compounds (eugenol,
cirsilineol, apigenin) [11]. The ancient systems of medi-
cine including Ayurveda, Greek, Roman, Siddha and
Unani, have mentioned its therapeutic applications in car-
diovascular disorders, diabetes and asthma [12,13]. How-
ever, only few studies are presently available that
documents its cardioprotective potential. Therefore with
the point of view that it might be interesting and possibly
fruitful to study the anti-apoptotic properties of Curcuma
longa and Ocimum sanctum (medicinal herbs widely used
for the treatment of various diseases in Ayurveda, the
Indian System of Medicine) and their effect on ventricular
function, the present investigation was planned to unravel
the molecular mechanism of the cardioprotective poten-
tial of these time tested herbal plants [8-13].
The relative involvement of apoptosis in cardiac I-R was
evaluated and the anti-apoptotic activity of these herbs
was investigated using immunohistochemical localiza-
tion of Bax and Bcl-2 proteins and TUNEL staining. To
correlate the apoptotic cell death and altered cardiac per-
formance during myocardial I-R changes in the hemody-
namic variables were also monitored in the present study.
Alterations in MAP, HR, LVEDP, (+) & (-)LVdP/dt were
monitored and recorded at preset time points throughout
the experimental period (1 hour 45 minutes). Cardiopro-
tective action of these herbal extracts was confirmed by
assessing the severity of pathological changes.
Methods
Experimental animals
Adult male Wistar rats, 10 to 12 weeks old, weighing 150
to 200 g were used in the study. The study protocol was
reviewed and approved by the Institutional Animal Ethics
Committee and conforms to the Indian National Science
Academy Guidelines for the Use and Care of Experimental
Animals in Research. Animals were obtained from the
Central Animal Facility of All India Institute of Medical
Sciences, New Delhi, India and were maintained under
standard laboratory conditions in the department animal
house. Rats were housed in polyacrylic cages (38 × 23 × 10
cm) with not more than four animals per cage. They were
housed in an air-conditioned room and were kept in
standard laboratory conditions under natural light and
dark cycles (approximately 14 h light/10 h dark) and
maintained at humidity 60 ± 5% and an ambient temper-
ature of 25 ± 2°C. All experiments were performed
between 9.0 and 16.0 h. The animals were allowed free
excess to standard diet (Ashirwad; Chandigarh) and tap
water ad libitum and allowed to acclimatize for one week
before the experiments. Commercial pellet diet contained
24% protein, 5% fat, 4% fiber, 55% carbohydrates, 0.6%
calcium, 0.3% phosphorous, 10% moisture and 9% ash
w/w.
Chemicals
All Chemicals were of analytical grade, purchased from
Sigma Chemical Co., St Louis, USA. Hydro-alcoholic
lyophilized extract of Ocimum sanctum was procured from
Dabur Research Foundation, and aqueous extract of Cur-
cuma longa was obtained from Sanat Research Laborato-
ries, India. The ABC staining kit and primary (Bax mouse
monoclonal IgG2b and Bcl-2 mouse monoclonal IgGI) &
secondary antibodies (Anti mouse IgG) were procured
from Santa Cruz Biotechnology, USA. TUNEL assay kit
was purchased from Roche Diagnostics, USA. Double dis-
tilled water was used in all biochemical assays.
Treatment protocol
The animals were randomly divided into four main
groups comprising of thirteen animals each.
Group 1 – Saline control group – Sham group
Rats were administered 0.9% normal saline for a month
and then sacrificed on the 31st day. The animals were sub-
jected to the entire surgical procedure and thread was
passed beneath the coronary artery but the LAD coronary
artery was not ligated.Page 2 of 12
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Cl at the doses of 25, 50, 100 & 200 mg/kg and Os at the
doses of 25, 75 & 150 mg/kg were screened in the murine
model of isoproterenol induced myocardial necrosis and
the optimum dose exhibiting maximum cardioprotective
effect was evaluated. Cl (100 mg/kg) and Os (75 mg/kg)
doses respectively were found to be the most effective in
functional recovery of the heart and favorable restoration
of biochemical and histopathological alterations. Hence,
these doses were selected for further evaluation singularly
as well as in combination in the ischemia and reperfusion
model of myocardial injury.
Group 2 – Ischemia and reperfusion group – Control IR
In this group, healthy experimental rats were adminis-
tered 0.9% normal saline for 30 days; thereafter, on the
31st day, the experimental animals were subjected to 45
min LAD coronary artery ligation and 60 min reperfusion
induced myocardial injury.
Group 3 – Curcuma longa treated group – Cl-IR
Aqueous extract of Curcuma longa (100 mg/kg) was
administered orally to healthy experimental animals for 1
month. On the 31st day, rats were subjected to 45 min
LAD ligation and 60 min reperfusion. The number of ani-
mals studied in this group was eleven.
Group 4 – Ocimum sanctum treated group – Os-IR
Hydroalcoholic extract of Ocimum sanctum (75 mg/kg)
was administered orally to healthy experimental animals
for 30 days, thereafter, on the 31st day the rats were sub-
jected to a protocol of 45 min LAD ligation and 60 min
reperfusion induced myocardial injury. The number of
animals studied in this group was thirteen.
The detailed experimental protocol used in the present
study is as follows:
1) Surgical procedure: infarction protocol and 
hemodynamic studies
Rats of all the experimental groups were anesthetized
intraperitoneally with pentobarbitone sodium (60 mg/
kg). Atropine was co-administered with the anesthetic to
keep the heart rate elevated especially during the surgery
protocol and reduce broncho-tracheal secretions. The
body temperature was monitored and maintained at
37°C throughout the experimental protocol. The neck
was opened with a ventral midline incision, and a trache-
ostomy was performed and the rats were ventilated with
room air from a positive pressure ventilator (Inco, India)
using compressed air at a rate of 70 strokes/min and a
tidal volume of 10 ml/kg. The right carotid artery was can-
nulated and the cannula filled with heparinized saline
was connected to the cardiac output monitor CARDIOSYS
CO-101 (Experimetria, Hungary) via a pressure transducer
for measurement of MAP and HR. The left jugular vein
was cannulated with polyethylene tube for continuos
infusion of 0.9% saline solution. A left thoractomy was
performed at the fifth intercostal space and the pericar-
dium was opened to expose the heart. The left anterior
descending coronary artery (LAD) was ligated 4–5 mm
from its origin by a 5-0 silk suture with a atraumatic nee-
dle and ends of this ligature were passed through a small
vinyl tube to form a snare. After the completion of the sur-
gical procedure, the heart was returned to its normal posi-
tion in the thorax. The thoracic cavity was covered with
saline-soaked gauze to prevent the heart from drying. The
animals were then allowed to stabilize for 15 min before
LAD ligation. Myocardial ischemia was induced by one
stage occlusion of the LAD by pressing the polyethylene
tubing against the ventricular wall and then fixing it in
place by clamping the vinyl tube with a hemostat. A wide
bore (1.5 mm) sterile metal cannula was inserted into the
cavity of the left ventricle from the posterior apical region
of the heart. The cannula was connected to a pressure
transducer (Gould Stathum P231D) and the whole sys-
tem was filled with heparinized saline (heparin 50 units/
ml). Left ventricular systolic and LVEDP was measured on
a multichannel polygraph (Grass 7D, USA) from the left
ventricular pressures curve at lower and higher sensitivity
of the preamplifier respectively. The maximal rate of rise
and fall of left ventricular pressure {peak (+) LVdP/dt and
peak (-) LVdP/dt} were measured by the electronic differ-
entiator from the signal output of the channel recording
left ventricular pressure. A bolus of heparin (30 IU) was
administered immediately before coronary artery occlu-
sion for prophylaxis against thrombus formation around
the snare. The animals then underwent 45 min of
ischemia, confirmed visually in situ by the appearance of
regional epicardial cynosis and ST-segment elevation. The
myocardium was reperfused by releasing the snare gently
for a period of 60 min. Successful reperfusion was con-
firmed by visualization of arterial blood flow through the
artery, appearance of hyperemia over the surface of the
previously ischemia cynotic segment. At the end of reper-
fusion period, animals were sacrificed for immunohisto-
chemical and histological studies by an overdose of
anesthesia.
2) Apoptotic studies
i) Immunostaining for the localization of Bax and Bcl-2 proteins
A monoclonal mouse anti-human Bcl-2 and Bax proteins
as the primary antibody were used for Bcl-2/Bax immuno-
histochemical staining. The ImmunoCruz Staining Sys-
tems utilizes a horseradish peroxidase (HRP)-streptavidin
complex for staining of formalin-fixed paraffin-embedded
myocardial sections. Indirect immunoperoxidase staining
was performed as described with some modifications
[27]. Briefly, 4–6 micron thick fixed paraffin tissue sec-
tions were subjected to the following immunohistochem-Page 3 of 12
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proteins using specific mouse monoclonal primary anti-
bodies. Sections are first blocked, and then incubated in
primary antibody. Biotinylated secondary antibody is
added followed by the addition of HRP-Straptavidin com-
plex. The target protein (Bax/Bcl-2) was visualized by
incubation in peroxidase substrate (H2O2) using DAB
(3,3' diaminobenzidine) as the chromogen.
ii) Terminal Deoxyribonucleotidyl Transferase-Mediated dUTP Nick 
End Labeling (TUNEL Assay)
Myocardial apoptosis was quantified by detection of DNA
fragmentation using the TUNEL technique. Briefly, the
enzyme terminal deoxynucleotidyl tranferase was used to
incorporate residues of digoxigenin nucleotide into 3' OH
ends of DNA fragments. The free end of cellular DNA was
labeled by incubating the specimens in streptavidin con-
jugated to horse radish peroxidase enzyme and peroxidase
substrate. The signal of terminal deoxynucleotidyl tran-
ferase-mediated dUTP nick end labeling (TUNEL) assay
was used to identify apoptotic cells using secondary reac-
tion with antibodies and DAB chromogen [25]. The slides
were counterstained in hematoxylin and total cell counts
and TUNEL positive cells in the specimens were deter-
mined by means of a light microscope. The cells with clear
nuclear labeling were defined as TUNEL positive cells. The
apoptotic cells i.e. TUNEL positive cells were expressed as
percentage of normal nuclei.
3) Histopathological studies
At the end of the experiment, myocardial tissue was
immediately fixed in 10% buffered neutral formalin solu-
tion. The tissues were carefully embedded in molten par-
affin with the help of metallic blocks, covered with
flexible plastic moulds and kept under freezing plates to
allow the paraffin to solidify. Cross sections (5 µm thick)
of the fixed myocardial tissues were cut. These sections
were stained with hematoxylin and eosin (H&E) and vis-
ualized under light microscope to study the light micro-
scopic architecture of the myocardium. The investigators
performing the histologic evaluation were blind to bio-
chemical and hemodynamic results and to treatment allo-
cation. The degree of necrosis was graded and scored as
follows:
Score (-): Absence of any inflammation, edema and
necrosis
Score (+): Focal areas of inflammation, edema and necro-
sis
Score (++): Patchy areas of inflammation, edema and
necrosis
Score (+++): Confluent areas of inflammation, edema and
necrosis
Score (++++): Massive areas of inflammation, edema and
necrosis
Statistical analysis
All numerical data in text, figures and tables are expressed
as the mean ± SD. Statistical analysis was performed by
one-way analysis of variance (ANOVA) or repeated meas-
ures ANOVA when data were compared at different time
points within a study group and for time courses between
study groups, followed by the Bonferroni post hoc test.
Differences were considered statistically significant at p <
0.05.
Results
Effects of Curcuma longa (Cl) and Ocimum sanctum 
(Os) on
1) Hemodynamic variables following I-R induced myocardial injury
i) Mean Arterial Pressure (MAP) and Heart Rate (HR)
The initial value of MAP and HR in the control IR group
was 124.7 ± 9.4 mm Hg (Graph 1) and 349 ± 22.6 beats/
min (Graph 2) respectively. Both the hemodynamic vari-
ables in the control IR group remained depressed
throughout the I-R duration as compared to sham base-
line values.
In the Cl treated group the baseline values of MAP (Graph
1) and HR (Graph 2) were 126.2 ± 13.9 mm Hg and 339
± 35.3 beats/min respectively. Cl treatment failed to sig-
nificantly restore both the hemodynamic parameters as
compared to control IR values at similar time points. The
value of MAP and HR remained more or less in the same
range as observed in the control IR group, during the
Table 1: Changes in Bax, Bcl-2 protein expression and TUNEL positivity in the different experimental groups
Bax (%) Bcl-2 (%) TUNEL (%)
Sham 3.5% ± 0.4 1.86 ± 0.17 0.2 ± 0.01
Control IR 9.80 ± 0.50### 1.45 ± 0.21 3.0 ± 0.20###
Cl-IR 4.4 ± 0.28** 7.7 + 0.62*** 0.8 ± 0.04*
Os-IR 6.4 ± 0.62* 1.80 ± 0.07 2.4 ± 0.09
Each value is expressed as Mean ± SD of eight experiments. ###p < 0.001 Vs Sham; *p < 0.05, **p < 0.01, ***p < 0.0001 Vs Control IR. Total cell 
counts and Bax, Bcl-2 and TUNEL positive cells in the specimens were determined by means of a light microscope. The Bax, Bcl-2 and TUNEL 
positive cells were expressed as percentage of normal nuclei.Page 4 of 12
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fusion as compared to control IR group.
The MAP recording in the Os treated group, before LAD
coronary artery ligation, was 123 ± 11.9 mm Hg (Graph
1). During the entire ischemic duration, the value of MAP
was more or less comparable to control IR recording at
similar time points. The MAP showed a gradual decline
with the progression of the reperfusion period. However,
at 60 min following reperfusion a significant (p < 0.05)
correction in the value of this parameter was recorded in
the Os treated group as compared to control IR group. The
initial value of HR in the Os treated group was 352 ± 25.1
beats/min (Graph 2). Os treatment did not bring about
any significant change in HR when compared to control
IR values during the entire duration of 45 min of ischemia
and 60 min of reperfusion.
Representative photomicrographs of ventricular tissue stain d for Bax r einFigure 1
Representative photomicrographs of ventricular tissue 
stained for Bax protein. Ischemia and reperfusion induced 
myocardial injury significantly increased the expression of 
Bax protein compared with non-ischemic tissue. Figures are 
representative of 5 separate experiments.
Curcuma longa (100 mg/kg) significantly attenuated the expression of Bax protein versus the con rol IR groupFigure 2
Curcuma longa (100 mg/kg) significantly attenuated the 
expression of Bax protein versus the control IR group.Page 5 of 12
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& (-) LVdP/dt}
In the control IR group, the (+) LVdP/dt and (-) LVdP/dt
values before LAD occlusion was 3140 ± 357 mm Hg/s
(Graph 3) and 3004 ± 323 mm Hg/s (Graph 4) respec-
tively. At 5 and 45 min post occlusion there was a signifi-
cant (p < 0.05) fall in (+)LVdP/dt in the control IR group
and reperfusion after 45 min of ischemia also brought
about a significant fall in (+) LVdP/dt at 15, 30, 45 (p <
0.05) & 60 (p < 0.001) min compared to sham baseline
values. (-)LVdP/dt in the control IR group remained sig-
nificantly depressed throughout the entire ischemic and
reperfusion duration, the maximal fall was recorded at the
end of the reperfusion period (p < 0.001) as compared to
sham.
The baseline values of (+) & (-) LVdP/dt in the Cl treated
group were 3202 ± 157 and 3142 ± 257 mm Hg/s respec-
tively (Graph. 3 & 4). Although there was a steady and
continuous fall in the (+) & (-) LVdP/dt in this group dur-
ing the experimental duration, the value of both these
parameters were higher throughout the 45 min of LAD
occlusion and 1 h reperfusion period as compared to the
control IR group. At 60 min post reperfusion, Cl signifi-
cantly improved myocardial contractility (p < 0.01) and
relaxation (p < 0.05) in comparison to control IR values at
same time points.
The baseline values of (+) & (-) LVdP/dt in the Os treated
group before LAD coronary artery occlusion was 3184 ±
125 and 2953 ± 165 mm Hg/s respectively (Graph 3 & 4).
Os treatment failed to significantly improve both myocar-
dial contractility and relaxation during ischemia and
reperfusion duration as compared to control IR values at
similar time points.
iii) Left Ventricular End Diastolic Pressure (LVEDP)
In the control IR group, following LAD coronary artery
occlusion, the LVEDP started rising gradually from its
baseline value of 3.3 + 0.91 mm Hg and it remained ele-
vated throughout the ischemic duration as compared to
sham (Graph 5). The increase in this variable was most
significant (p < 0.001) at 45 min of ischemia. On reper-
fusion, there was a marked and sudden fall in the value of
this parameter during the reperfusion phase, but it
remained significantly increased at 5 (p < 0.001) and 15
(p < 0.01) min post reperfusion compared to the sham
group.
The baseline value of LVEDP in the Cl treated group was
3.4 ± 0.25 mm Hg (Fig 5). Cl treatment significantly cor-
rected the elevated LVEDP levels at 15 min (p < 0.001), 25
min (p < 0.01), 35 min (p < 0.05) and 45 min (p < 0.001)
as compared to control IR values. Thereafter during the
reperfusion duration the value of LVEDP in the Cl treated
group was comparable to control IR recordings at the sim-
ilar time points.
The baseline value of LVEDP in the Os treated group was
3.8 + 0.64 mm Hg (Graph 5). After 5 min of coronary
artery occlusion LVEDP increased significantly and
remained elevated during LAD occlusion period in com-
Ocimum sanctum (75 mg/kg) treatment did not result in signif-icant alteration in the expression of Bax protein versus the co rol IR groupFigure 3
Ocimum sanctum (75 mg/kg) treatment did not result in signif-
icant alteration in the expression of Bax protein versus the 
control IR group.Page 6 of 12
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value of LVEDP was significantly lower at 15 and 45 min
of ischemia (p < 0.01) as compared to control IR values at
the same time points. Post reperfusion the LVEDP values
in the Os treated group were comparable to control IR val-
ues.
2) Myocardial apoptotic parameters following I-R induced myocardial 
injury
i) Myocyte Bax protein expression
Slight Bax immunoreactivity (3.5% ± 0.4%) was observed
in the myocytes of the sham group (Table 1). Ischemia
and reperfusion induced myocardial injury significantly
increased the expression of Bax protein (p < 0.001) com-
pared with non-ischemic tissue from 3.50 ± 0.40 to 9.80
± 0.50% (Fig 1). Bax expression was significantly attenu-
ated to 4.4 ± 0.28% and 6.4 ± 0.62% respectively in the Cl-
IR (p < 0.01, Fig 2) and Os-IR (p < 0.05, Fig. 3) treated
groups as compared to control IR.
ii) Myocyte Bcl-2 protein expression
Bcl-2 protein was expressed in the sham myocardium as
indicated by slight positive Bcl-2 immunoreactivity in the
myocytes. The basal expression of Bcl-2 was found to be
1.86 ± 0.17% (Table 1). Coronary occlusion and reper-
Representative photomicrographs of ventricular tissue stain d for Bcl-2 proteinFigure 4
Representative photomicrographs of ventricular tissue 
stained for Bcl-2 protein. Coronary occlusion and reper-
fusion resulted in a slight reduction (non significant) in Bcl-2 
expression in the control IR group compared to non-
ischemic tissue. Figures are representative of 5 separate 
experiments.
Curcuma longa (100 mg/kg) upregulated Bcl-2 protein as indi-cated by dark brown positive immunorea tivity comp red to ontrol IR groupFigure 5
Curcuma longa (100 mg/kg) upregulated Bcl-2 protein as indi-
cated by dark brown positive immunoreactivity compared to 
control IR group.Page 7 of 12
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Bcl-2 expression compared with non-ischemic tissue (Fig.
4). Significant upregulation in the expression of Bcl-2 was
observed in the Cl (p < 0.001) treated group in compari-
son to control IR (Fig. 5). However, in the Os (75 mg/kg,
Fig. 6) group there was no significant change in the
expression of Bcl-2 protein and it was found to be compa-
rable to control IR group i.e. 1.80 ± 0.07%.
iii) TUNEL positivity
TUNEL positivity was expressed as percentage of total nor-
mal nuclei. Slight TUNEL positive staining was detected in
the sham group (0.2% ± 0.01%, Table 1). However, the
number of TUNEL positive cells expressed as percentage
of total normal nuclei was significantly increased subse-
quent to ischemia and reperfusion induced myocardial
injury in the control IR group (3.0 ± 0.2%, p < 0.001, Fig.
7) compared to sham non-ischemic myocardium as indi-
cated by increased intensity of TUNEL staining. The
TUNEL positivity was significantly attenuated to 0.8 ±
0.04% in the Cl-IR (p < 0.05, Fig. 8) group as compared to
control IR. However, Os (75 mg/kg, Fig. 9) treated group
did not demonstrate any significant anti-apoptotic activ-
ity in comparison to control IR group. The percentage of
Ocimum sanctum (75 mg/kg) treated group subjected to 45 min of ischemia and 1 h of rep rfusion failed to demonstrate any significan  change in the expr sion of Bcl-2 protein ver-sus the co trol IR groupFigur  6
Ocimum sanctum (75 mg/kg) treated group subjected to 45 
min of ischemia and 1 h of reperfusion failed to demonstrate 
any significant change in the expression of Bcl-2 protein ver-
sus the control IR group.
Representative photomicrographs of ventricular tissue stain d for nick-end labeling (TUNEL) for DNA breaksFigure 7
Representative photomicrographs of ventricular tissue 
stained for nick-end labeling (TUNEL) for DNA breaks. In 
the Control IR group a large number of TUNEL positive cells 
are observed subsequent to ischemia and reperfusion injury. 
Figures are representative of atleast 5 separate experiments.Page 8 of 12
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3) Myocardial histology and histopathology following I-R induced 
myocardial injury
Microscopic histology revealed that the non-infarcted
myocardium in the sham group was characterized by an
organized pattern and shows normal architecture of the
myocardium (Table 2). Contrastively, on histological
evaluation, rat hearts, subjected to I-R (Control IR) dem-
onstrated marked edema, confluent areas of myonecrosis,
myofiber loss and mild inflammation as compared to
those in the sham group (Table 2). Cl (100 mg/kg) treated
rats demonstrated marked structural improvement spe-
cially with regard to the degree of myonecrosis, infiltra-
tion of inflammatory cells and edema as compared to the
control IR group. However, Os (75 mg/kg) treatment
failed to preserve the myocardial cellular integrity as evi-
denced by patchy areas of myonecrosis, edema and mod-
erate degree of inflammation in this group, which was
comparable to that observed in control IR group (Table
2).
Discussion
Prolonged severe ischemia leads to cardiac cell death.
Necrosis previously was regarded as the only mode of cell
death, whereas, now there is accumulating evidence that
in addition to overt necrosis, a subset of cells also die by
apoptosis, (the programmed cell death). The relative con-
tributions of necrosis and apoptosis to cell death in
ischemia and reperfusion are still open to debate,
although necrosis appears to dominate during ischemia,
Relative to the control IR group the number of TUNEL posi-tive cells was significantly decreased by treatment with Cur-cuma longa (100 mg/kg)Figure 8
Relative to the control IR group the number of TUNEL posi-
tive cells was significantly decreased by treatment with Cur-
cuma longa (100 mg/kg).
Ocimum sanctum (75 mg/kg) treated group subjected to 45 min of ischemia and 1 h of rep rfusion failed to significantly decrease TUNEL positivity as compared to control IR groupFigure 9
Ocimum sanctum (75 mg/kg) treated group subjected to 45 
min of ischemia and 1 h of reperfusion failed to significantly 
decrease TUNEL positivity as compared to control IR group.Page 9 of 12
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now evidence that apoptosis occurs during sustained
ischemia and when reperfusion follows shorter periods of
ischemia [14,15].
The progressive loss of cardiomyocytes in a heart that is
already compromised leads to further deterioration of car-
diac function, conduction disturbances due to degenera-
tion of SA, AV and inter-nodal pathway, cardiac
remodeling and cardiomyopathy [3,4]. The fact that
apoptosis plays a role in the tissue damage seen after myo-
cardial infarction has pathological and therapeutic impli-
cations. If indeed cardiomyocyte apoptosis plays an
important role in initiation and progression of cardiac
diseases, drugs that effectively and specifically inhibit
apoptosis might be useful therapeutic agents for attenuat-
ing myocardial injury due to I-R [16].
In reperfused ischemic hearts increase in oxidative stress,
and decrease in antioxidant defense has been reported to
lead to cardiac dysfunction partly due to apoptosis [4,17].
However, whether or not plant derived agents, known to
possess antioxidant activity may reduce myocardial apop-
tosis induced by I-R, and thus improve ventricular func-
tion and thus attenuate MI has not been directly
investigated.
In the present study, TUNEL positivity and the immuno-
histochemical localization of Bax, an inducer of apoptosis
and Bcl-2 proteins, inhibitors of apoptosis were studied to
delineate the involvement of apoptosis in I-R induced
injury. In order to correlate whether the inhibition of
apoptosis has any direct effect on cardiac function, hemo-
dynamic function was also monitored and recorded at
preset time points throughout the experimental period.
Cardioprotective activity of these herbs was confirmed by
assessing the severity of pathological changes.
Results of the present study demonstrated that in the con-
trol IR group myocardial I-R injury triggered apoptotic cell
death. Increase in TUNEL staining observed in the control
IR group suggests a role of apoptosis in contribution of
myocardial injury following I-R. A slight reduction in Bcl-
2 expression and significant increase in Bax expression as
compared with sham group was observed in the control IR
group. This observation receives support from earlier
studies [18,19]. In addition, consistent with increase in
apoptotic cell death, post ischemic reperfusion injury also
resulted in significant depression of left ventricular
dynamics, peripheral hemodynamics (MAP) and HR.
Cl treatment significantly reduced the percentage of
TUNEL positive cells Vs the control IR group, demonstrat-
ing its significant anti-apoptotic activity. Treatment with
Cl was associated with greater Bcl-2 and attenuated Bax
expression as compared to the control IR group. Curcu-
min, the active ingredient of the rhizome of the turmeric
plant (Curcuma longa), a commonly used spice, has been
reported to prevent cancer in animal tumor models possi-
bly by its apoptosis-inducing and antiproliferative influ-
ences [20-22]. However, in the present study, in contrast
to earlier reports, marked anti-apoptotic activity of Cl was
observed.
Previously we reported that cardioprotective effect of Cl
results from the suppression of oxidative stress and corre-
lates with the improved ventricular function [23]. How-
ever, till date there are no in vivo studies, which have
explored the relationship between the putative anti-apop-
totic effects of Cl on the functional recovery of ischemia
reperfused myocardium. The present study demonstrates
that Cl treatment resulted in preserved left ventricular
function as reflected by a significant increase in the indices
of contractility (+) LVdP/dt, relaxation (-) LVdP/dt and
decrease in preload (LVEDP). It is speculated that, Cl treat-
ment may have indirectly restored blood flow in the
ischemic regions towards normal as assessed by its effi-
cacy in improving cardiac performance, especially correct-
ing the ischemia and reperfusion-induced increase in
LVEDP. However, Cl did not significantly affect MAP and
HR. The anti-apoptotic effect of Cl, improved ventricular
functions with improved histologic features suggests that
treatment with this agent may exert cardioprotective
effects following coronary ligation and reperfusion.
Os treatment did not demonstrate any significant anti-
apoptotic activity as determined by TUNEL staining and
immunohistochemical results. No significant change in
the expression of Bax and Bcl-2 proteins was observed
with Os treatment as compared to control IR in the
Table 2: Light microscopic changes observed in the different experimental groups
Necrosis Edema Inflammation
Sham - - -
Control IR ++ +++ +
Cl-IR + ++ +
Os-IR ++ ++ +
The relative pathological changes are ranked from - = No change; + = Focal change; ++ = Patchy change; +++ = Confluent change and ++++ = 
Massive change.Page 10 of 12
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icantly reduced the surrogate preload marker LVEDP as
compared to control IR. However, it failed to significantly
improve the left ventricular contractility and relaxation
and failed to significantly modulate the histopathologic
alterations compared to control IR group. Results of the
present study demonstrate that Os does not possess signif-
icant cardioprotective effects.
The relationship between the possible anti-apoptotic
effects of Cl on the functional recovery of ischemic reper-
fusion injury of the heart has been well elucidated by the
dosing protocol of the present study. The exact mecha-
nism by which Cl may reduce myocardial ischemia and
reperfusion induced myocardial apoptosis is far from
clear presently. Recently it has been reported that Curcu-
min, an active principle of Curcuma longa reduces cardi-
omyocytic apoptosis. Curcumin an inhibitor of NF-
kappaB, ameliorated the surge of pro-inflammatory
cytokines during cardiopulmonary bypass (CBP) and
decreased the occurrence of cardiomyocytic apoptosis
after global cardiac ischemia/reperfusion injury. The
authors proposed that by inhibiting NF-kappaB activa-
tion, the up-regulation of cardiac proinflammatory genes
can be ameliorated, and the activation of matrix metallo-
proteinase can be decreased during CPB, thereby lessen-
ing severity of cardiac mechanical dysfunction after global
cardiac ischemia/reperfusion injury [24,25]. However, in
the present study, we have used the aqueous extract of Cl
and have proposed a different mechanism for its antiap-
optotic effect and correlated it with the ventricular func-
tion. Based on the present findings it can be speculated
that Cl may attenuate apoptosis via a number of mecha-
nisms: Upregulation of Bcl-2 may result in formation of
heterodimers with Bax, resulting in no/fewer free Bax pro-
tein available for homodimerization. If Bax homodimers
predominate cell death will occur, but when Bcl-2 and Bax
heterodimererization prevails cells can survive. Substan-
tial evidence indicates that the mitochondria play a criti-
cal regulatory role in the signal transduction pathway
leading to apoptosis [4,26]. Loss of contractile cells in the
heart poses an additional workload on the remaining via-
ble myocytes that may be unbearable, resulting in patho-
logic stimuli and death signals. In the present study, In
contrast to Os, Cl treatment may have salvaged these myo-
cytes and prevented cell loss induced by apoptosis. His-
topathologic evaluation further confirms the
cardioprotective potential of such a treatment.
In order to elucidate, the additional mechanisms by
which Cl may reduce myocardial apoptosis and the
potential clinical implications of such actions, we need to
further investigate the relationship of the detrimental
effects of key oxidants and apoptotic signals with reper-
fusion injury. This will lead to a better understanding of
basic physiological and pathological mechanisms rele-
vant to myocardial ischemia and reperfusion injury and
give new insight to novel therapeutic targets and strategies
for its treatment. However, the present study provides a
lead for further exploring other mechanisms contributing
to the cardioprotective effect of Cl. Whether the conclu-
sions drawn on the basis of the current data can be extrap-
olated to clinical setting, remains to be defined by well-
controlled studies in-patients. Nonetheless, the results of
the present study are rather encouraging, because they
could unravel a new therapeutic approach for the preven-
tion and/or treatment of ischemic heart disease.
Conclusion
In the present investigation it was observed that subse-
quent to ischemia and reperfusion injury, Curcuma longa
treated group demonstrated significant anti-apoptotic
property, which might contribute to the observed preser-
vation in cardiac function and cardioprotective effects.
Furthermore, the myocardial salvaging effects of Curcuma
longa were supported by histopathological studies. In con-
trast, Ocimum sanctum did not exhibit any significant anti-
apoptotic effects and cardioprotection.
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